Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation

By Artini Paolo   Monti Massimiliano   Matteucci Cristiana   Valentino Valeria   Cristello Francesca   Genazzani Andrea  

Gynecological Endocrinology, Vol. 22, Iss. 8, 2006-08 ,pp. : 465-470

Informa Healthcare

Access to resources Recommend Favorite

Vascular endothelial growth factor and its soluble receptor in ovarian pathology

By Artini PG   Cristello F   Monti M   Cela V   Battaglia C   D'Ambrogio G   Genazzani AR  

Gynecological Endocrinology, Vol. 21, Iss. 1, 2005-07 ,pp. : 50-56

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis

By Xiao Jinsong   Chen Shuangyun   Zhang Chunlian   Chang Shang  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 187-191

Informa Healthcare

Access to resources Recommend Favorite

Infertility. Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF

By Benifla J.L.  

Human Reproduction, Vol. 16, Iss. 7, 2001-07 ,pp. : 1376-1381

Oxford University Press

Access to resources Recommend Favorite

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome

By Pau Elena   Alonso-Muriel Isabel   Gómez Raul   Novella Edurne   Ruiz Amparo   García-Velasco Juan A.   Simón Carlos   Pellicer Antonio  

Human Reproduction, Vol. 21, Iss. 6, 2006-06 ,pp. : 1453-1460

Oxford University Press

Access to resources Recommend Favorite